Skin reactions due to antiepileptic drugs: Several case-reports with long-term follow-up

International Journal of Immunopathology and Pharmacology

Volumn 16, Issue 1, 2003, Pages 89-93

  Feliciani, C ^a,b   Verrotti, A ^a   Coscione, G ^a   Toto, P ^a   Morelli, F ^a   Di Benedetto, A ^a   Salladini, C ^a   Chiarelli, F ^a   Tulli, A ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b Clinica Dermatologica   (Italy)

Author keywords

Adverse effects; Antiepileptic drugs; Skin drug reaction

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CORTICOSTEROID; IMMUNOGLOBULIN; LAMOTRIGINE; METHYLPREDNISOLONE; PHENOBARBITAL; VALPROIC ACID;

ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERSENSITIVITY; MALE; PRIORITY JOURNAL; SEIZURE; SKIN ALLERGY; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; CASE REPORT; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; DRUG HYPERSENSITIVITY; FOLLOW UP; PATHOPHYSIOLOGY; PRESCHOOL CHILD; RASH; TIME;

ADULT; AGED; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DRUG HYPERSENSITIVITY; DRUG THERAPY, COMBINATION; EXANTHEMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; TIME FACTORS;

EID: 0037271251     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200301600113     Document Type: Article

References (35)

1. Sterker M. and J. Berrouschot. 1995. Fatal course of toxic epidermal necrolysis under treatment with lamotrigine. Int. J. Clin. Pharmacol. Therapeutics 33:595.
2. Waagner D.C. 1997. Hypersensitivity to carbamazepine. N. Engl. J. Med. 336:376.
3. Schlienger R.G. and N.H. Shear. 1988. Antiepileptic drug Hypersensitivity Syndrome. Epilepsia 39:3.
4. Shear N.H. and S.P. Spielberg. 1988. Anticonvulsant Hypersensitivity Syndrome. J. Clin. Invest. 82:1826.
5. Brown T S. and J.E. Appel. 1999. Hypersensitivity reaction in a child due to lamotrigine. Ped. Dermatol. 16:46.
6. Stern S. and P. Tennis. 1997. Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study. Neurology 4982:542.
7. Paquet P., E. Jacob, P. Damas and G.E. Pierard. 2001. Treatment of drug-induced toxic epidermal necrolysis (Lyell's syndrome) with intravenous human immunoglobulins. Burns 27:652.
8. Corne P., O. Dereure, J.J. Guilhou and O. Jonquet. 2001. Toxic epidermal necrolysius treated with intravenous immunoglobulins. Rev. Med. Interne 22:491.
9. Valero J., A. Vazquez-Barro, E. Saez, E. Lopez-Suso and F. Martelo. 1997. Toxic epidermal necrolysis and corticosteroid therapy. An. Med. Interna 14:650.
10. Rzani B. and O. Correia. 1999. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reaction. Lancet 353:2190.
11. Pelekanos J. and P. Camfield. 1991. Allergic Rash due to Antiepileptic Drugs: Clinical Features and Management. Epilepsia 32:554.
12. Hyson C. and M. Sadler. 1997. Cross sensitivity of skin rashes with antiepileptic drugs. Can. J. Neurol. Sci. 24: 245.
13. Besag F.M. and A.H. Guberman. 1999. Lamotrigine associated rash: risk/benefit consideration in adult and in children. Epilepsia 40:985.
14. Shlienger R.G. and S.R. Knowles. 1998. Lamotrigine- associated anticonvulsant hypersensitivity syndrome. Neurology 51:1172.
15. Konishi T. and Y. Naganuma. 1993. Carbamazepine-induced skin rash in children with epilepsy. Eur. J. Pediatr. 152:605.
16. Wolkenstein P. and D. Charue. 1995. Metabolic predisposition to cutaneous Adverse Drug Reactions. Arch. Dermatol. 131:544.
17. Friedmann P.S. and I. Stickland. 1994. Investigation of Mechanisms in toxic Epidermal necrolysis Induced by Carbamazepine. Arch. Dermatol. 130:598.
18. Merk H.F., J. M. Baron, Y. Kawakubo, M. Herti and F. Jugert. 1998. Metabolites and allergic drug reactions. Clin. Exp. Allergy 28:21.
19. Conti P., D. Kempuraj and T.C. Theoharides. 2001. Mechanism by which IL-16 generated by mast cells mediates allergic inflammation. Int. J. Immunopathol. Pharmacol. 14:1.
20. Kasahara S., H. Fugo, E.L. Cooper and H. Wago. 2001. Preliminary Evidence of Modulating Th1 Cytokine after Allergen Challenge. Int. J. Immunopathol. Pharmacol. 14:63.
21. Baron J.M. and H.F. Merk. 2001. Drug metabolism in the skin. Curr. Opin. Allergy Clin. Immunol. 1:287.
22. Yoshino S., H. Hayashi, S. Taneda, H. Takano, M. Sagai and Y. Mori. 2002. Effects of diesel exhaust particle extracts on Th1 and Th2 immune responses in mice. Int. J. Immunopathol. Pharmacol. 15:13.
23. Patriarca G., A. Buonomo, C. Roncallo, M. Del Ninno, E. Pollastrini, A. Milani, T. De Pasquale, G. Gasbarrini, D. Schiavino and E. Nucera. 2002. Desensitization in cow milk allergy: immunological findings. Int. J. Immunopathol. Pharmacol. 15:53.
24. Feliciani C. and A. Tulli. 2002. Topical cyclosporin in the treatment of dermatologic diseases. Int. J. Imunopathol. Pharmacol. 15:89.
25. Perrella A., O. Perrella, C. Sbreglia, P. Conca and G. Tarantino. 2001. Hepatic and peripheral T-lymphocyte patterns in patients with chronic hepatitis C infection: what correlation with histological activity? Int. J. Immunopathol. Pharmacol. 14:103.
26. Merk HF., J.M. Baron, M. Herti, D. Niederau and A. Rubben. 1997. Lymphocyte activation in allergic reactions elicited by small- molecular-weight compounds. Int. Arch. Allergy Immunol. 113:173.
27. Baron J.M., D. Holler, R. Schiffer, S. Frankenberg, M. Neis, H.F. Merk and F.K. Jugert. 2001. Expression of multiple cytochrome p450 enzymes and multidrug resistance associated trasport proteins in human skin keratinocytes. J. Invest. Dermatol. 116:541.
28. Baron J.M., L.B. Goh, D. Yao, C.R. Wolf and T. Friedberg. 2001 Modulation of p450 CYP3A4-dependent metabolism by P-glycoprotein: implications for p450 phenotyping. J. Pharmacol. Exp. Ther. 296:351.
29. French L.E. and J. Tschopp. 2000. Fas-mediated cell death in toxic epidermal necrolysis and graft-versus-host disease: potential for therapeutic inhibition. Scweiz. Med. Wochenschr. 130:1656.
30. Wehrii P., I. Viard, R. Bullani, J. Tschopp and L.E. French. 2000. Death receptors in cutaneous biology and disease. J. Invest. Dermatol. 115:141.
31. Acharya A. and S.M. Singh. 2001. Effect of TNFα on the induction of apoptosis in murine macrophage: role of ICE. Int. J. Immunopathol. Pharmacol. 14:5.
32. Agostini M., B. Di Marco, G. Nocentini and D.V. Delfino. 2002. Oxidative stress and apoptosis in immune diseases. Int. J. Imunopathol. Pharmacol. 15:157.
33. 2-induced apoptosis of thymocytes involves mobilization of divalent cations. Int. J. Imunopathol. Pharmacol. 15:193.
34. Samuelsson A., T.L. Towers and J.V. Ravetch. 2001 Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 291:484.
35. Theoharides T.C., M. Alexandrakis, D. Kempuraj and M. Lytinas. 2001. Anti-inflammatory actions of flavonoids and structural requirements for new design. Int. J. Immunopathol. Pharmacol. 14:119.